Email Updates

Search form

You are here

AVAC's Blog: P-Values

  • From AVAC’s Research & Reality webinar series, this recent webinar focused on essential questions about what recent trials do—and do not—tell us about whether women will want or use prevention tools including microbicide gels, rings and oral tenofovir-based PrEP.

    Download the recording and slides here.

    April 17, 2014
  • Over the past few years, the pace of scale-up of voluntary medical male circumcision for HIV prevention has finally begun to acclerate around Africa. Many different stakeholders have worked to make this happen—service providers, community educators, wives and mothers, and the millions of men who have stepped up to undergo this simple procedure, which reduces the risk of HIV infection by roughly 70 percent, for life.

    April 16, 2014
  • From February 11-13 more than 80 advocates from throughout sub-Saharan Africa gathered in Harare, Zimbabwe, for AVAC’s Advocacy Partners’ Forum, an annual event to take stock of recent developments in HIV prevention research and implementation and to develop a strategy for the coming year.

    April 1, 2014
    General
  • The following piece is adapted from a presentation given at the AVAC Partners’ Forum by Mannasseh Phiri, a columnist for Zambia’s Sunday Post and long-time HIV prevention advocate.

    Several things really! First, at least one night every week I’m awake thinking which 1,000 words to write in my HIV/AIDS weekly newspaper column—before my deadline.

    April 1, 2014
    General
    Mannasseh Phiri
  • It’s been five years since we announced the first class of talented advocates in the AVAC Advocacy Fellowship Program—and in February, AVAC was thrilled to welcome seven new Fellows. These individuals joined the outgoing 2013 Fellows in Harare, Zimbabwe, for a joint wrap-up and orientation Fellows Workshop.

    February 21, 2014
    General
  • See the powerful speech on the continued and urgent need for an HIV vaccine from the AVAC Advocacy Fellow, and read the conference highlights.

    October 31, 2013
  • In July, AVAC and Internews in Kenya organized a journalists briefing on PrePex, a non-surgical device for voluntary medical male circumcision (VMMC) pre-qualified by the World Health Organization (WHO). (Click here for more on this process.) This was the first in a planned series of journalist “cafés” designed to spark conversation about VMMC and the role of non-surgical devices.

    October 30, 2013
  • The Good Participatory Practice Guidelines continue to be rolled out in various contexts and are increasingly seen as an essential tool for engaging stakeholders in research. In recent months, AVAC collaborated with partners in Kenya, South African and Uganda for focused feedback sessions about several new GPP implementation tools that are in the works. The new tools take users through the process of developing a strategic community and stakeholder engagement plan.

    October 29, 2013
    General
  • Lillian Mworeko from ICW-East Africa and an AVAC Fellowship Host Supervisor in 2012 gave a dynamic presentation on the June 11 USAID/FHI 360 webinar “Hormonal Contraception and HIV: What Do the Evidence and WHO Technical Statement Mean for Programs?” Mworeko highlighted the critical importance of addressing women’s reproductive health and HIV prevention and/or treatment needs with integrated services that provide full information on the risks and benefits of all available options—including injectable hormonal contraceptives.

    June 30, 2013
  • On June 19-20 in Kigali, 15 civil society organizations (CSOs) completed a two-day training on HIV prevention with a focus on pre-exposure prophylaxis (PrEP). The meeting was organized by 2013 AVAC Prevention Research Advocacy Fellow Josephine Kamarebe and her host organization, the Health Development Initiative.

    June 20, 2013

Pages